Duration of protection against hepatitis A for the current two-dose vaccine compared to a three-dose vaccine schedule in children-Reference-Cited by-同舟云学术

Duration of protection against hepatitis A for the current two-dose vaccine compared to a three-dose vaccine schedule in children

Published:2013-04 Issue:17 Volume:31 Page:2152-2155
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Raczniak Gregory A.,Thomas Timothy K.,Bulkow Lisa R.,Negus Susan E.,Zanis Carolyn L.,Bruce Michael G.,Spradling Philip R.,Teshale Eyasu H.,McMahon Brian J.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference20 articles.

1. Secular trends in hepatitis A virus infection among Alaska Natives;Bulkow;J Infect Dis,1993

2. Impact of recurrent epidemics of hepatitis a virus infection on population immunity levels: Bristol Bay, Alaska;Peach;J Infect Dis,2002

3. Immunogenicity of an inactivated hepatitis A vaccine in Alaska Native children and Native and non-Native adults;McMahon;J Infect Dis,1995

4. Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults;Hammitt;J Infect Dis,2008

5. Long-term immunogenicity of inactivated hepatitis A vaccine: Follow-up at 15 years;Byrd;Journal of Pediatric Infectious Diseases,2010

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Immunological and Epidemiological Effectiveness of Pediatric Single-Dose Vaccination against Hepatitis A 9 to 11 Years after Its Implementation in the Tyva Republic, the Russian Federation;Vaccines;2024-08-10

2. Seroprevalence of hepatitis A virus antibodies among children and adolescents living in Northern Thailand: an implication for hepatitis A immunization;Scientific Reports;2023-10-13

3. Immunogenicity persistence of hepatitis A vaccines Healive® and Havrix® among children:15 years follow-up and long-term prediction;Human Vaccines & Immunotherapeutics;2023-06-26

4. Immunisation status during biologic therapy for hidradenitis suppurativa and psoriasis;JEADV Clinical Practice;2023-06-15

5. One or two doses of hepatitis A vaccine in universal vaccination programs in children in 2020: A systematic review;Vaccine;2022-01